Cargando…

The prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based study

Studies on prognosis of different metastasis patterns in patients with different breast cancer subtypes (BCS) are limited. Therefore, we identified 7862 breast cancer patients with distant metastasis from 2010 to 2013 using Surveillance, Epidemiology, wand End Results (SEER) population-based data. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haiyong, Zhang, Chenyue, Zhang, Jingze, Kong, Li, Zhu, Hui, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432264/
https://www.ncbi.nlm.nih.gov/pubmed/28038448
http://dx.doi.org/10.18632/oncotarget.14300
_version_ 1783236597788966912
author Wang, Haiyong
Zhang, Chenyue
Zhang, Jingze
Kong, Li
Zhu, Hui
Yu, Jinming
author_facet Wang, Haiyong
Zhang, Chenyue
Zhang, Jingze
Kong, Li
Zhu, Hui
Yu, Jinming
author_sort Wang, Haiyong
collection PubMed
description Studies on prognosis of different metastasis patterns in patients with different breast cancer subtypes (BCS) are limited. Therefore, we identified 7862 breast cancer patients with distant metastasis from 2010 to 2013 using Surveillance, Epidemiology, wand End Results (SEER) population-based data. The results showed that bone was the most common metastatic site and brain was the least common metastatic site, and the patients with HR+/HER2− occupied the highest metastasis proportion, the lowest metastasis proportion were found in HR-/HER2+ patients. Univariate and multivariate logistic regression analysis were used to analyze the association, and it was found that there were significant differences of distant metastasis patterns in patients with different BCS(different P value). Importantly, univariate and multivariate Cox regression analysis were used to analyze the prognosis. It was proven that only bone metastasis was not a prognostic factor in the HR+/HER2-, HR+/HER2+ and HR-/HER2+ subgroup (all, P > 0.05), and patients with brain metastasis had the worst cancer specific survival (CSS) in all the subgroups of BCS (all, P<0.01). Interestingly, for patients with two metastatic sites, those with bone and lung metastasis had best CSS in the HR+/HER2- (P<0.001) and HR+/HER2+ subgroups (P=0.009) However, for patients with three and four metastatic sites, there was no statistical difference in their CSS (all, P>0.05).
format Online
Article
Text
id pubmed-5432264
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-54322642017-05-17 The prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based study Wang, Haiyong Zhang, Chenyue Zhang, Jingze Kong, Li Zhu, Hui Yu, Jinming Oncotarget Research Paper Studies on prognosis of different metastasis patterns in patients with different breast cancer subtypes (BCS) are limited. Therefore, we identified 7862 breast cancer patients with distant metastasis from 2010 to 2013 using Surveillance, Epidemiology, wand End Results (SEER) population-based data. The results showed that bone was the most common metastatic site and brain was the least common metastatic site, and the patients with HR+/HER2− occupied the highest metastasis proportion, the lowest metastasis proportion were found in HR-/HER2+ patients. Univariate and multivariate logistic regression analysis were used to analyze the association, and it was found that there were significant differences of distant metastasis patterns in patients with different BCS(different P value). Importantly, univariate and multivariate Cox regression analysis were used to analyze the prognosis. It was proven that only bone metastasis was not a prognostic factor in the HR+/HER2-, HR+/HER2+ and HR-/HER2+ subgroup (all, P > 0.05), and patients with brain metastasis had the worst cancer specific survival (CSS) in all the subgroups of BCS (all, P<0.01). Interestingly, for patients with two metastatic sites, those with bone and lung metastasis had best CSS in the HR+/HER2- (P<0.001) and HR+/HER2+ subgroups (P=0.009) However, for patients with three and four metastatic sites, there was no statistical difference in their CSS (all, P>0.05). Impact Journals LLC 2016-12-27 /pmc/articles/PMC5432264/ /pubmed/28038448 http://dx.doi.org/10.18632/oncotarget.14300 Text en Copyright: © 2017 Wang et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research Paper
Wang, Haiyong
Zhang, Chenyue
Zhang, Jingze
Kong, Li
Zhu, Hui
Yu, Jinming
The prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based study
title The prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based study
title_full The prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based study
title_fullStr The prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based study
title_full_unstemmed The prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based study
title_short The prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based study
title_sort prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a seer based study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432264/
https://www.ncbi.nlm.nih.gov/pubmed/28038448
http://dx.doi.org/10.18632/oncotarget.14300
work_keys_str_mv AT wanghaiyong theprognosisanalysisofdifferentmetastasispatterninpatientswithdifferentbreastcancersubtypesaseerbasedstudy
AT zhangchenyue theprognosisanalysisofdifferentmetastasispatterninpatientswithdifferentbreastcancersubtypesaseerbasedstudy
AT zhangjingze theprognosisanalysisofdifferentmetastasispatterninpatientswithdifferentbreastcancersubtypesaseerbasedstudy
AT kongli theprognosisanalysisofdifferentmetastasispatterninpatientswithdifferentbreastcancersubtypesaseerbasedstudy
AT zhuhui theprognosisanalysisofdifferentmetastasispatterninpatientswithdifferentbreastcancersubtypesaseerbasedstudy
AT yujinming theprognosisanalysisofdifferentmetastasispatterninpatientswithdifferentbreastcancersubtypesaseerbasedstudy
AT wanghaiyong prognosisanalysisofdifferentmetastasispatterninpatientswithdifferentbreastcancersubtypesaseerbasedstudy
AT zhangchenyue prognosisanalysisofdifferentmetastasispatterninpatientswithdifferentbreastcancersubtypesaseerbasedstudy
AT zhangjingze prognosisanalysisofdifferentmetastasispatterninpatientswithdifferentbreastcancersubtypesaseerbasedstudy
AT kongli prognosisanalysisofdifferentmetastasispatterninpatientswithdifferentbreastcancersubtypesaseerbasedstudy
AT zhuhui prognosisanalysisofdifferentmetastasispatterninpatientswithdifferentbreastcancersubtypesaseerbasedstudy
AT yujinming prognosisanalysisofdifferentmetastasispatterninpatientswithdifferentbreastcancersubtypesaseerbasedstudy